← Eichor
Condition: Appendiceal Neoplasms Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Appendiceal Neoplasms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Phase 2 · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05913674An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Phase 2 · 2 location(s) · Prakash Pandalai · NCT04779554Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04847063Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
Phase 2 · 1 location(s) · University of California, Irvine · NCT07693452Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C M
Phase 1/Phase 2 · 53 location(s) · Revolution Medicines, Inc. · NCT06128551Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Phase 4 · 1 location(s) · Cedars-Sinai Medical Center · NCT07124351Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
NA · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT05780684A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Phase 1/Phase 2 · 9 location(s) · Apollo Therapeutics Ltd · NCT06399757Molecular Characterisation of Appendiceal Cancer
Phase N/A · 1 location(s) · The Christie NHS Foundation Trust · NCT05364788Target-specific immunoPET Imaging of Digestive System Carcinoma
NA · 1 location(s) · RenJi Hospital · NCT06715839A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06207305Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT05919758Molecular Profiling for Risk Stratification in Appendiceal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07587268A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherap
NA · 1 location(s) · Yale University · NCT07291180Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT04907643Genetics of Appendix Cancer Study
Phase N/A · 1 location(s) · Andreana Holowatyj, PhD, MSCI · NCT05734430A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendice
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT05947838PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gast
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT04329494Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
NA · 1 location(s) · University of California, Davis · NCT06101277Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05472948Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NA · 344 location(s) · Alliance for Clinical Trials in Oncology · NCT07283939EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastroint
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT06263088
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.